This study demonstrates that miR-671-3p is a predominant positive regulator of glioma progression, suggesting that the miR-671-3p/CKAP4 axis may serve as a possible therapeutic target or biomarker in glioma [142]. The gene discussed is CKAP4; the disease is glioma.